← Leaderboards
Nathan D Pankratz
University Of Washington
$1,953,304
Attributed
$5,127,997
Total exposure
2
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.5M · FY2020–25$2M$1.5M$1M$500K$0
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$5,127,997 · 2
By mechanism
R01$5,127,997 · 2
Top collaborators
- Nicholas L Smith4 shared
- Daniel Evan Bauer3 shared
- Alexander P Reiner3 shared
- Mariza De Andrade2 shared
Most similar at University Of Washington
Same institution · by research overlap
- Evan E. Eichler$97,393,877
- Alexander P Reiner$25,408,009
- Mary-Claire King$31,748,898
- Glennis Amelia Logsdon$793,098
- Thalia Papayannopoulou$16,580,758
Others in their field
Other Emerging Leaders on “Heritability”
- Leonard Freedman · Leidos Biomedical Research, Inc.$41,527,040
- Lynn Briscoe · Leidos Biomedical Research, Inc.$23,339,595
- Maria C Carrillo · Indiana University Indianapolis$19,489,876
- Amy Brower · American College Of Medical Genetics$8,744,067
- Pradeep Natarajan · Massachusetts General Hospital$7,868,359
- Jennifer Below · Univ Of North Carolina Chapel Hill$6,400,207
Research focus
HeritabilityMethodologyGenome-WideGenotypeHuman BiologyLungEnsureGenome SequencingComplexGenomic VariationExperimental DesignsBiologicalLeadershipBiologyClinical Trials DesignCollaborationsBlood CoagulationGenesCardiovascular SystemCollectionDna SequenceGenomicsAlgorithmsNational Heart, Lung, And Blood Institute
Grant awards (7)
Structural Variation and Hematological Traits$694,774
R01 · FY2025 · HL
Structural Variation and Hematological Traits$687,693
R01 · FY2024 · HL
Structural Variation and Hematological Traits$765,621
R01 · FY2023 · HL
Structural and Nucleotide Variation as Genomic Risks for Venous Thrombosis: TOPMED and INVENT Collaboration$720,705
R01 · FY2023 · HL
Structural and Nucleotide Variation as Genomic Risks for Venous Thrombosis: TOPMED and INVENT Collaboration$743,125
R01 · FY2022 · HL
Structural and Nucleotide Variation as Genomic Risks for Venous Thrombosis: TOPMED and INVENT Collaboration$743,125
R01 · FY2021 · HL
Structural and Nucleotide Variation as Genomic Risks for Venous Thrombosis: TOPMED and INVENT Collaboration$772,954
R01 · FY2020 · HL